EndoGastric Solutions’ mission is to combine the most advanced concepts in gastroenterology and surgery to develop products and procedures that address unmet needs in gastrointestinal diseases. Our proprietary technology platform, the EsophyX® fastener delivery system, is designed to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids refluxing back into the esophagus. Cleared by the FDA in 2007, the technology has continued to evolve with the launch of the company’s third generation device, the EsophyX Z device in 2015. The device is commercially available in the United States and used by both gastroenterologists and surgeons to treat GERD. The EsophyX device is used to perform the company’s TIF® procedure for reflux (Transoral Incisionless Fundoplication)—a surgical solution performed without the need for external incisions through the skin that enables physicians to reconstruct the gastroesophageal valve from within the stomach and correct the root cause of GERD.